Automating Cell-Based Assays and Reducing Variability and Time to Results
Webinar Date/Time: Thu, Dec 14, 2023 11:00 AM EST
Cell-based assays play a critical role in assessing potency for traditional biologics and advanced therapeutics. In this presentation, the development of a cell-based potency assay on an automated platform is discussed.
Register Free: https://www.biopharminternational.com/bp_w/reducing-variability
Event Overview:
Cell-based assays play a critical role in assessing potency for traditional biologics and advanced therapeutics. For all analytical methods, increasing accuracy and precision while decreasing variability are critical to optimizing a method. For a cell-based assay, due to biologic nature, the variable material inputs provide a challenge. Therefore, other aspects of the analytical method need to be assessed for improvement opportunities. Removing variability through automation can help increase assay robustness and ruggedness, as well as reduce time to achieve results. In this presentation, the development of a cell-based potency assay on an automated platform is discussed.
Key Learning Objectives:
- Advantages (safety, performance, quality) of bioassay automation
- Comparisons between manual and bioassays automation
- How to adapt to automated bioassays
Who Should Attend:
- Procurement
- Head* of Mfg
- Head* of Ops
- Head* of R&D
- Head* of Sourcing
- Alliance Manager/External AM
- Head** of CMC
- Head** of Mfg
- Head** of R&D
- Head** of Analytical Development
- Head** of Product Development
- Head** of Formulation Development
- Consultants
*Head or a senior level of management **Head or any level of management
Speaker:
Luke Mercer
Manager, Bioassay
Catalent
Luke Mercer is the Bioassay Manager at Catalent’s Research Triangle Park location in North Carolina, and oversees assay development and QC testing for cell-based assays, ELISA’s and PCR. He has over 25 years of experience ranging from genomics startup, clinical stage biotech and contract organizations. Previously, he lead a discovery team at Cambrex, and prior to that was at GPC Biotech and Alphagene.
Register Free: https://www.biopharminternational.com/bp_w/reducing-variability
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
